The use of doses of tens of thousands of milligrams of vitamin C per day may be the most unacknowledged successful research in medicine. High doses were advocated almost immediately after ascorbic acid was isolated. Notable early medical pioneers of high-dose vitamin C therapy are Claus Washington Jungeblut (1898-1976); William J. McCormick (1880-1968); and Frederick R. Klenner (1907-1984). More recently, important work has been published by Hugh D. Riordan (1932-2005) and Robert F. Cathcart III (1932 – 2007). Jungeblut first published on ascorbate as prevention and treatment for polio, in 1935. Also in 1935, Jungeblut showed that vitamin C inactivated diphtheria toxin. By 1937, Jungeblut demonstrated that ascorbate inactivated tetanus toxin. Between 1943 and 1947, Klenner, a specialist in diseases of the chest, cured 41 cases of viral pneumonia with vitamin C. By 1946, McCormick showed how vitamin C prevents and also cures kidney stones; by 1957, how it fights cardiovascular disease. Beginning in the 1960s, Robert F. Cathcart, M.D. used large doses of vitamin C to treat pneumonia, hepatitis, and eventually AIDS. For more three decades, beginning in 1975, Hugh D. Riordan, M.D. and his team have successfully used large doses of intravenous vitamin C against cancer. The medical literature has virtually ignored nearly 75 years of physician reports and laboratory and clinical studies on successful high-dose ascorbate therapy. Read more
- Is Vitamin C Really as Effective as Exercise?
- Vitamin C May Be Beneficial for Asthmatic Children, Study Suggests
- Health Benefits of Vitamin C and Best Natural Sources
- 16 Foods High in Vitamin C